More than 285 internists will meet this coming Thursday and Friday, January 26 and 27, in Valladolid at the XVII Meeting of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine (SEMI), where the main diagnostic and therapeutic novelties in these …
More than 285 internists will meet this coming Thursday and Friday, January 26 and 27, in Valladolid at the XVII Meeting of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine (SEMI), where the main diagnostic and therapeutic novelties in these fields.
With the presence of experts from all over the country and representation of the group of patients and other medical-scientific societies, and under an inter and multidisciplinary approach, topics of scientific relevance such as the role of nutrition and exercise in hospitalized frail patients will be addressed. , ultrasound in the morphofunctional assessment in Internal Medicine, insulinization in special profiles of patients, the past, future and present of the person with obesity or anticoagulation of the patient with obesity, among many others of relevance.
will also present the new algorithm for the comprehensive approach to hospital hyperglycemiaand there will be a lecture on the treatment of obesity in the elderlyas well as about diagnostic and therapeutic novelties leaders in the fields of diabetes, obesity and nutrition. Among other issues, the new ADA/EASD 2022 consensus will also be addressed, as well as the main initiatives and projects that the Group has been working on over the last year (MIDIA registry or training and research activities -Customized Course-, as well as other algorithms such as the Type 2 Diabetes Approach SEMI 2023). The role of the internist, as a specialist with a global and comprehensive vision of the patient, is key in the management of people with diabetes and obesity to avoid their associated complications and comorbidities.
In addition to different workshops, including one on adapted physical exercise, there will be a meeting of researchers and a MFG workshop for internists, as well as a competition for clinical cases. The Serrano Ríos Award for the Best Research Project 2023 will also be awarded.
The inauguration of the meeting will take place by Dr. Juana Carretero, president of the Spanish Society of Internal Medicine (SEMI); Dr. Pedro Pablo Casado, coordinator of SEMI’s Diabetes, Obesity and Nutrition GT; Dr. José Manuel Barragán, president of the Castilian-Leonese-Cántabrian Society of Internal Medicine (SOCALMI); Dr. Francisco Javier Escalada, president of the Spanish Society of Endocrinology and Nutrition (SEEN); Dr. Antonio Pérez, president of the Spanish Diabetes Society (SED), and Dr. Albert Lecubre, vice president of the Spanish Society for the Study of Obesity (SEEDO). The inaugural conference, moderated by Dr. Carretero, will be held under the title “The path of the hero”.
Data of interest and prevalence of obesity and diabetes
Obesity is a “chronic disease”, as declared by most official bodies such as the WHO in 1997 or the EU in 2021. It is estimated that by 2023 the prevalence figures in Spain will be 30% of the adult population, with growth in all ages, especially worrying in children and adolescents with an expected growth of 1.9% per year, representing 2.43% of total health spending.
Diabetes in Spain: prevalence and incidence
Regarding the prevalence of diabetes in Spain, it is estimated that 1 in 7 adults in Spain have diabetes and it is estimated that 13.8% of the Spanish population has Type 2 Diabetes Mellitus (DM2), of which only 7.8% are diagnosed. Every year, 11.6 cases are diagnosed for every 100,000 inhabitants, which means 385,000 new cases of DM2 per year. With regard to Internal Medicine in particular, according to the registry, population profile and the average performance of the internist, it is estimated that more than 20% of patients who attend Internal Medicine have diabetes.